Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

30.92
+2.8610.19%
Post-market: 30.930.0101+0.03%19:59 EDT
Volume:16.03M
Turnover:483.86M
Market Cap:7.21B
PE:-49.63
High:31.45
Open:28.34
Low:28.31
Close:28.06
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:1.69
T/O Rate:7.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:22.26
PE(LYR):60.36

Loading ...

Stock Track | Hims & Hers Health Plunges 16.09% in Pre-Market on Q1 Loss, $33M GLP-1 Restructuring Costs

Stock Track
·
May 12

Refile-Hims Hers Shares Fall 16% Premarket After Co Misses Q1 Revenue Estimate (Adds Dropped Words)

THOMSON REUTERS
·
May 12

Hims & Hers Shares Fall 16% Premarket After Co Misses Q

THOMSON REUTERS
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Hims & Hers Health Inc : JP Morgan Cuts Target Price to $33 From $35

THOMSON REUTERS
·
May 12

24H | Quantum Computing Soars 16%; Plug Power Jumps 9%; MARA Drops 3%; Cleanspark Drops 7%; AST SpaceMobile Sinks 10%; Hims & Hers Tumbles 14%

Tiger Newspress
·
May 12

Stock Track | Hims & Hers Health Plunges 13.49% in Post-Market After Q1 Earnings Miss, Swing to Loss

Stock Track
·
May 12

Stocks to Watch: BuzzFeed, Hims & Hers, GoPro, GitLab

Dow Jones
·
May 12

Hims & Hers Health Swings to 1Q Loss as Weight-Loss Pivot Drives Up Costs -- 2nd Update

Dow Jones
·
May 12

Hims & Hers Misses Revenue Estimates as Strategy Shift Hits Sales, Shares Tumble 12%

Reuters
·
May 12

Notable companies reporting after market close

TIPRANKS
·
May 12

Hims & Hers' Intl Expansion Softens Blow from U.S. Sales Decline -- Market Talk

Dow Jones
·
May 12

Hims & Hers Health Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Hims & Hers CFO expects return to profit in 2027

Reuters
·
May 12

Hims Exec Says Expects Clearer View on Some Peptides by End-July, More Updates by Year-End

THOMSON REUTERS
·
May 12

Hims & Hers Health Took Write Downs on Ingredients and Inventory Related to Compounding Glp-1S and One-Time M&a Costs - CFO

THOMSON REUTERS
·
May 12

Hims Exec Says International Expansion to See Heaviest Investment in Coming Quarters - Conf Call

THOMSON REUTERS
·
May 12

Hims Exec Says Company Incurred About $33 Mln in Restructuring Costs Tied to Glp-1 Supply Chain Write-Downs - Conf Call

THOMSON REUTERS
·
May 12

Hims & Hers Health Saw Record Traffic and App Downloads After Shifting to FDA-Approved Glp-1S, CFO Says

THOMSON REUTERS
·
May 12

Hims Exec Says Company May Not Be First to Market in Peptides, Aims to Scale Offering When It Launches

THOMSON REUTERS
·
May 12